韩志鸿,刘 洁

急性脑梗死是一种严重的脑血管病变，其发病机制错综复杂，其中，炎症反应和脂质代谢异常在其发生和发展中起着关键作用。文章深入剖析了外周血中一系列炎症标志物（涵盖炎症细胞、细胞因子以及急性期反应蛋白等）与急性脑梗死之间的内在联系，揭示这些标志物能够有效映射机体的炎症状况，且与脑梗死的起病、演进以及预后均展现出紧密的关联性。此外，文章还细致探讨了脂质代谢失衡，特别是低密度脂蛋白胆固醇与高密度脂蛋白胆固醇水平波动对急性脑梗死风险的具体影响。研究结果显示，外周血炎症指标与脂质代谢异常之间存在着显著的相互作用，这一重要发现为急性脑梗死的早期诊断以及预后评估开辟了新的视角与策略，有助于临床医生制定更为有效的治疗与干预措施。

急性脑梗死；外周血炎症；脂质代谢；低密度脂蛋白；高密度脂蛋白

[1] Edwards M D,Hughes T A T.Managing blood pressure in acute cerebral infarction[J].J Neurol,2021,268(6):2294-2296. [2] Lee E C,Ha T W,Lee D H,et al.Utility of Exosomes in Ischemic and Hemorrhagic Stroke Diagnosis and Treatment[J].Int J Mol Sci,2022,23(15). [3] Chen W,Chen Y,Wu L,et al.Identification of cell death-related biomarkers and immune infiltration in ischemic stroke between male and female patients[J].Front Immunol,2023,14:1164742. [4] Smith C J,Emsley H C,Gavin C M,et al.Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume,stroke severity and long-term outcome[J].BMC Neurol,2004,4:2. [5] Ma Y,Chen Z,He Q,et al.Spatiotemporal lipidomics reveals key features of brain lipid dynamic changes after cerebral ischemia and reperfusion therapy[J].Pharmacol Res,2022,185:106482. [6] Shang W,Zhang Y,Xue L,et al.Evaluation of collateral circulation and short-term prognosis of patients with acute cerebral infarction by perfusion-weighted MRI[J].Ann Palliat Med,2022,11(4):1351-1359. [7] Busl K M,Greer D M.Hypoxic-ischemic brain injury:pathophysiology,neuropathology and mechanisms[J].NeuroRehabilitation, 2010, 26(1):5-13. [8] Libby P.The changing landscape of atherosclerosis[J].Nature,2021,592(7855):524-533. [9] Attiq A,Afzal S,Ahmad W,et al.Hegemony of inflammation in atherosclerosis and coronary artery disease[J].Eur J Pharmacol,2024, 966:176338. [10] Asada Y,Yamashita A,Sato Y,et al.Thrombus Formation and Propagation in the Onset of Cardiovascular Events[J].J Atheroscler Thromb,2018,25(8):653-664. [11] Zhang T,Deng W,Deng Y,et al.Mechanisms of ferroptosis regulating oxidative stress and energy metabolism in myocardial ischemia-reperfusion injury and a novel perspective of natural plant active ingredients for its treatment[J].Biomed Pharmacother, 2023,165:114706. [12] Wu Q,Liu J,Mao Z,et al.Ligustilide attenuates ischemic stroke injury by promoting Drp1-mediated mitochondrial fission via activation of AMPK[J].Phytomedicine,2022,95:153884. [13] Liang S,Zhang J,Zhang Q,et al.Longitudinal tracing of white matter integrity on diffusion tensor imaging in the chronic cerebral ischemia and acute cerebral ischemia[J].Brain Res Bull,2020,154:135-141. [14] Han S,Zhang M,Jeong Y Y,et al.The role of mitophagy in the regulation of mitochondrial energetic status in neurons[J].Autophagy, 2021,17(12):4182-4201. [15] SveinssonÓ,KjartanssonÓ,Valdimarsson E M.[Cerebral ischemia/infarction-diagnosis and treatment][J].Laeknabladid, 2014,100(7-8):393-401. [16] Kriz J.Inflammation in ischemic brain injury:timing is important[J].Crit Rev Neurobiol,2006,18(1-2):145-157. [17] Qin C,Zhou L Q,Ma X T,et al.Dual Functions of Microglia in Ischemic Stroke[J].Neurosci Bull,2019,35(5):921-933. [18] Planas A M.Role of microglia in stroke[J].Glia,2024,72(6):1016-1053. [19] Li Y,Liu B,Zhao T,et al.Comparative study of extracellular vesicles derived from mesenchymal stem cells and brain endothelial cells attenuating blood-brain barrier permeability via regulating Caveolin-1-dependent ZO-1 and Claudin-5 endocytosis in acute ischemic stroke[J].J Nanobiotechnology,2023,21(1):70. [20] Liu F,McCullough L D.Inflammatory responses in hypoxic ischemic encephalopathy[J].Acta Pharmacol Sin,2013,34(9):1121-1130. [21] Rodney T,Osier N,Gill J.Pro-and anti-inflammatory biomarkers and traumatic brain injury outcomes:A review[J].Cytokine,2018, 110:248-256. [22] Chen Y,Huang W,Li Z,et al.The effect of acupuncture on the expression of inflammatory factors TNF-α,IL-6,IL-1 and CRP in cerebral infarction:A protocol of systematic review and metaanalysis[J].Medicine(Baltimore),2019,98(24):e15408. [23] Li Y,Hong Z,Li S,et al.Efficacy of Butylphthalide in Combination with Edaravone in the Treatment of Acute Ischemic Stroke and the Effect on Serum Inflammatory Factors[J].Dis Markers,2023,2023:9969437. [24] Boghozian R,Falcione S,Jickling G C.Inflammatory Markers and Risk of Cardiovascular Events in Ischemic Stroke[J].Stroke, 2023,54(5):1300-1302. [25] Elkind M S.Inflammatory mechanisms of stroke[J].Stroke,2010,41(10 Suppl):S3-8. [26] Li J,Pan Y,Xu J,et al.Residual Inflammatory Risk Predicts Poor Prognosis in Acute Ischemic Stroke or Transient Ischemic Attack Patients[J].Stroke,2021,52(9):2827-2836. [27] Rizo-Téllez S A,Sekheri M,Filep J G.C-reactive protein:a target for therapy to reduce inflammation[J].Front Immunol,2023,14:1237729. [28] Rose-John S.Interleukin-6 Family Cytokines[J].Cold Spring Harb Perspect Biol,2018,10(2). [29] Del Giudice M,Gangestad S W.Rethinking IL-6 and CRP:Why they are more than inflammatory biomarkers,and why it matters[J]. Brain Behav Immun,2018,70:61-75. [30] He Y,Ma N,Xing C,et al.Novel IL-6-secretingγδT cells increased in patients with atherosclerotic cerebral infarction[J].Mol Med Rep, 2015,11(2):1497-1503. [31] Elkind M S.Inflammatory markers and stroke[J].Curr Cardiol Rep,2009,11(1):12-20. [32] Monsour M,Croci D M,Agazzi S,et al.Contemplating IL-6,a double-edged sword cytokine:Which side to use for stroke pathology?[J]. CNS Neurosci Ther,2023,29(2):493-497. [33] Chen A Q,Fang Z,Chen X L,et al.Microglia-derived TNF-αmediates endothelial necroptosis aggravating blood brain-barrier disruption after ischemic stroke[J].Cell Death Dis,2019,10(7):487. [34] He X,Wang L,Wang H,et al.Factors associated with acute cardiac injury and their effects on mortality in patients with COVID-19[J]. Sci Rep,2020,10(1):20452. [35] Chow Y L,Teh L K,Chyi L H,et al.Lipid Metabolism Genes in Stroke Pathogenesis:The Atherosclerosis[J].Curr Pharm Des,2020, 26(34):4261-4271. [36] Bian K Y,Jin H F,Sun W,et al.DCA can improve the ACI-induced neurological impairment through negative regulation of Nrf2 signaling pathway[J].Eur Rev Med Pharmacol Sci,2019,23(1):343-351. [37] Ravnskov U,de Lorgeril M,Diamond D M,et al.LDL-C does not cause cardiovascular disease:a comprehensive review of the current literature[J].Expert Rev Clin Pharmacol,2018,11(10):959-970. [38] Qin L Z,Li W,Huang Y,et al.PTX3 expression in the plasma of elderly ACI patients and its relationship with severity and prognosis of the disease[J].Eur Rev Med Pharmacol Sci,2016,20(19):4112-4118. [39] Pan Y,Wangqin R,Li H,et al.LDL-C levels,lipid-lowering treatment and recurrent stroke in minor ischaemic stroke or TIA[J].Stroke Vasc Neurol,2022,7(4):276-284. [40] Sato F,Nakamura Y,Kayaba K,et al.TG/HDL-C ratio as a predictor of stroke in the population with healthy BMI:The Jichi Medical School Cohort Study[J].Nutr Metab Cardiovasc Dis,2022,32(8):1872-1879. [41] QiaoZhen X,AiGuo M,Tong W,et al.Correlation between of small dense low-density lipoprotein cholesterol with acute cerebral infarction and carotid atherosclerotic plaque stability[J].J Clin Lab Anal,2019,33(6):e22891. [42] Sung E M,Saver J L.Statin Overuse in Cerebral Ischemia Without Indications:Systematic Review and Annual US Burden of Adverse Events[J].Stroke,2024,55(8):2022-2033. [43] Libby P,Hansson G K.From Focal Lipid Storage to Systemic Inflammation:JACC Review Topic of the Week[J].J Am Coll Cardiol, 2019,74(12):1594-1607. [44] Das U N.Infection,Inflammation,and Immunity in Sepsis[J].Biomolecules,2023,13(9). [45] Xu H,Wu B,Jiang F,et al.High fatty acids modulate P2X(7)expression and IL-6 release via the p38 MAPK pathway in PC12 cells[J]. Brain Res Bull,2013,94:63-70. [46] Jiang X,Tang N,Liu Y,et al.Integrating network analysis and pharmacokinetics to investigate the mechanisms of Danzhi Tiaozhi Decoction in metabolic-associated fatty liver disease(MAFLD)[J].J Ethnopharmacol,2024,318(Pt B):117008. [47] Yalcinkaya M,Fotakis P,Liu W,et al.Cholesterol accumulation in macrophages drives NETosis in atherosclerotic plaques via IL-1βsecretion[J].Cardiovasc Res,2023,119(4):969-981. [48] Kim K Y,Shin K Y,Chang K A.Potential Biomarkers for Post-Stroke Cognitive Impairment:A Systematic Review and Meta-Analysis[J]. Int J Mol Sci,2022,23(2). [49] Kamtchum-Tatuene J,Jickling G C.Blood Biomarkers for Stroke Diagnosis and Management[J].Neuromolecular Med,2019,21(4):344-368. [50] Angerio A D,Bialko M F,White B M.C-reactive protein,stroke,and statins[J].Crit Care Nurs Q,2007,30(2):161-165. [51] Yoshida M,Mizoi M,Saiki R,et al.Relationship between metabolic disorders and relative risk values of brain infarction estimated by protein-conjugated acrolein,IL-6 and CRP together with age[J].Clin Chim Acta,2011,412(3-4):339-342.

点击下载PDF